Write-up: Information has been received from a physician concerning a female consumer with no pertinent history who on approximately 05-SEP-2007 was vaccinated SC with a 0.65 ml dose of Zostavax. On approximately 05-SEP-2007 the patient developed a cerebral hemorrh"age and was hospitalized. The condition was considered to be immediately life-threatening per the physician. No further information was provided. There was no product quality complaint involved. Additional information has been requested.